Event Details
January 01, 2016
Description
Projected clinical trials for Parkinson's patients.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| patients | person | 2 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_029540.jpg
Page 2 of 4 of an LA Times interview with Alan Trounson (dated May 29, 2013) discussing the state of stem cell research in California. Trounson outlines plans to request $70 million from the CIRM board to establish a network of clinics and compares California's collaborative research environment (funded by Proposition 71's $3 billion) to the competitive environments of Harvard and Australia. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.
Related Events
Events with shared participants
ODYSSEY Phase 3 program: A comprehensive clinical trial program for an investigational LDL cholesterol lowering therapy (Praluent), involving 14 global trials and over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A comprehensive clinical trial program for PRALUENT, including 14 global trials with over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A large-scale clinical trial program for the investigational LDL cholesterol-lowering therapy, Praluent (alirocumab), involving over 23,500 patients in 14 global trials.
Date unknown • Global
The ODYSSEY clinical trial program was conducted for the drug Praluent.
Date unknown • worldwide
ODYSSEY clinical trial program.
2025-12-01
ODYSSEY Phase 3 program
Date unknown • Global
Stroke rehabilitation treatment program using imitation-based therapies.
Date unknown • Unspecified medical/research setting
Visit to Norman Geschwind's epilepsy clinic where he demonstrated symptoms of temporal lobe epilepsy (hypergraphia, religious conversion, hyposexuality) in patients to the narrator.
Date unknown • Epilepsy Clinic
Outbreak of food poisoning involving more than 100 patients.
2012-05-01 • Upstate New York
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event